Nrf2 inhibition overcomes regorafenib resistance in well-differentiated sorafenib-resistant hepatocellular carcinoma cells
Scientific Reports - Nrf2 inhibition overcomes regorafenib resistance in well-differentiated sorafenib-resistant hepatocellular carcinoma cells